Effect of Pretreatment of S-Ketamine On Postoperative Depression for Breast Cancer Patients
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study aims to investigate the effect of the pretreatment of S-ketamine on postoperative depression (POD) for breast cancer patients with mild/moderate depression. METHODS: The present randomized, double-blinded controlled trial included 303 breast cancer patients with mild/moderate depression from June 2017 to June 2018. All patients were randomly divided into three groups: (1) control group, patients treated with normal saline; (2) racemic ketamine group, patients treated with racemic ketamine; (3) S-ketamine group, patients treated with S-ketamine. Operation time, blood loss and hospital stay and complications were recorded. The Visual Analog Scale (VAS) score was recorded, and the Hamilton Rating Scale for Depression (HAMD-17) scores, serum brain-derived neurotrophic factor (BDNF) and 5-hydroxytryptamine (5-HT) were measured at three days, one week, one month and three months after surgery. RESULTS: No significant difference was found in operation time, bleeding volume and complication rate. In both groups, the VAS scores at one day and three days after surgery were significantly lower. The HAMD-17 scores were significantly lower, and the serum levels of both BDNF and 5-HT were remarkably higher at three days, one week and one month after surgery. Meanwhile, the HAMD-17 scores were remarkably lower, while the serum levels of BDNF and 5-HT were remarkably higher in the S-ketamine group. The BDNF and 5-HT levels were negatively correlated with the HAMD-17 score. CONCLUSION: S-ketamine is more effective for reducing POD for breast cancer patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although the 0.125 mg-kg dose of racemic ketamine in the study by Liu et al. might have been too low for optimal treatment efficacy.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Liu et al., 2020
In the citing paper
“Group differences were no longer significant after 3 months.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Liu et al., 2020
In the citing paper
“Two studies from the same research group (Liu et al., 2020;Wang et al., 2020) compared racemic and S-ketamine and found S-ketamine to be superior to racemic ketamine in treating pain and depression”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Liu et al., 2020
In the citing paper
“After 3 days, 1 week, and 1 month, depression scores were significantly lower in the ketamine groups compared to control, with significantly larger effects for S-ketamine than racemic ketamine.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Liu et al., 2020
Citations
Cites
Neural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718 · cited 2×
“All patients were randomly divided into three groups: [1] control group (n1⁄4 100), patients received an intravenous injection of 2ml of normal saline after analgesia induction; [2] racemic ketamine group (n1⁄4 102), patients received an intravenous injection of 2ml of 0.”
BackgroundMethodKetamine—its pharmacology and therapeutic uses
white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474
Depression and anxiety in women with early breast cancer: five year observational cohort study
Burgess, C., Cornelius, V., Love, S., Graham, J., Richards, M., & Ramirez, A. (2005) · BMJ · doi:10.1136/bmj.38343.670868.d3 · Cited by 1,334
Exercise treatment for depression
Dunn, A. L., Trivedi, M. H., Kampert, J. B., Clark, C. G., & Chambliss, H. O. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.09.003 · Cited by 1,208
Exercise for the Treatment of Depression
Knapen, J., Vancampfort, D., Schoubs, B., Probst, M., Sienaert, P., Haake, P., Peuskens, J., & Pieters, G. (2009) · The Open Complementary Medicine Journal · doi:10.2174/1876391x00901010078 · Cited by 911
Ketamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )
Mion, G., & Villevieille, T. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12099 · Cited by 711 · cited 1×
“Ketamine is a widely used anesthetic in analgesia, and has presently become more and more popular for treating anti-depression, particularly for resistant depression [10,11].”
BackgroundMajor depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Depression and postoperative complications: an overview
Ghoneim, M. M., & O’Hara, M. W. (2016) · BMC Surgery · doi:10.1186/s12893-016-0120-y · Cited by 488
BDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368
Laje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.031 · Cited by 213 · cited 1×
“It was also found that BDNF polymorphism is associated with the antidepressant efficacy of ketamine in depressed patients [26].”
Background
Cited by
Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06027-y · Cited by 162
Randomized trial of ketamine masked by surgical anesthesia in patients with depression
Lii, T. R., Smith, A. E., Flohr, J. R., Okada, R. L., Nyongesa, C. A., Cianfichi, L. J., Hack, L. M., Schatzberg, A. F., & Heifets, B. D. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00140-x · Cited by 138
Luo, T., Deng, Z., Ren, Q., Mu, F., Zhang, Y., & Wang, H. (2024) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2024.111447 · Cited by 75
Self-citationAntidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73
Agnorelli, C., Spriggs, M. J., Godfrey, K., Sawicka, G., Bohl, B., Douglass, H. M., Fagiolini, A. M., Hashemi, P., Carhart-Harris, R. L., Nutt, D. J., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106132 · Cited by 68
Metadata
- Authors
- Liu, P., Li, P., Li, Q., Yan, H., Shi, X., Liu, C., Zhang, Y., & Peng, S.
- Affiliations
- Shanghai University of Traditional Chinese Medicine (CN)
- Anesthesiology, Fengcheng Hospital of Fengxian District, Shanghai, China
- Corresponding author
- Peng, Sheng
- Venue
- Journal of Investigative Surgery
- Publisher
- Informa UK Limited
- Published
- 2020-01-16
- Volume
- 34
- Issue
- 8
- Pages
- 883-888
- ISSN
- 0894-1939 (ISSN-L)
- 1521-0553
- OpenAlex
- W3000460077
- Cited by
- 103
- References
- 28
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 26 · 2023: 22 · 2022: 7 · 2021: 7 · 2020: 2
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Investigative Surgery (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Shanghai Municipal Commission of Health and Family Planning
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- esketamine, postoperative depression, breast cancer, racemic ketamine, brain-derived neurotrophic factor, serotonin, surgical stress, postoperative pain
- MeSH terms
- Breast Neoplasms, Depression, Double-Blind Method, Female, Humans, Ketamine, Postoperative Pain, Pain, Postoperative
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Pretreatment of S-Ketamine On Postoperative Depression for Breast Cancer Patients. https://app.cochat.ai/papers/10.1080/08941939.2019.1710626
- The paper
- Liu, P., Li, P., Li, Q., Yan, H., Shi, X., Liu, C., Zhang, Y., & Peng, S. (2021). Effect of Pretreatment of S-Ketamine On Postoperative Depression for Breast Cancer Patients. Journal of Investigative Surgery. https://doi.org/10.1080/08941939.2019.1710626
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.